SpaceX employees and early investors are facing their first real opportunity to sell shares, though a sharp decline in the stock price will significantly limit their gains. The company’s first lockup expiration is scheduled for August 6, 2026, unlocking roughly 911.5 million shares held by insiders for trading on the open market. SpaceX’s approach to…

Five months after slashing 40% of its workforce in the name of artificial intelligence, Block is making a strong case that the painful decision was the right one. CEO Jack Dorsey cut over 4,000 jobs at Block earlier this year, shrinking the company from more than 10,000 employees to under 6,000 workers. Dorsey framed the…

Scammers are sending fake party invitations that appear to come from trusted contacts, including friends, family members, coworkers, and neighbors. At first glance, the emails look entirely legitimate, often carrying the sender’s real email signature, phone number, website, and even a personal photo. The Federal Trade Commission has issued a warning about this phishing scheme,…

SanDisk posted fiscal fourth-quarter revenue of $8.79 billion, topping Wall Street consensus estimates of $8.64 billion by a meaningful margin. The company also delivered adjusted earnings per share of $39.25, well above analyst estimates of $34.37, marking a strong end to the fiscal year. SanDisk attributed its revenue growth to approximately one-third higher volumes and…

The Protect College Sports Act is heading toward a full Senate vote, potentially arriving as soon as this week amid growing pressure to act before the summer recess. The bill was co-authored by Sen. Ted Cruz (R-Texas) and Sen. Maria Cantwell (D-Wash.), drawing bipartisan support for a sweeping overhaul of college athletics governance. The Senate…

Danish drugmaker Novo Nordisk built an early empire on the back of semaglutide, the active ingredient powering both its blockbuster Ozempic and Wegovy treatments. Ozempic was originally developed to treat type 2 diabetes before patients and physicians discovered its dramatic weight-loss effects, setting off a global pharmaceutical gold rush. Novo rebranded semaglutide as Wegovy specifically…